# Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Feasibility Trial CANADA

> **NCT02838680** · NA · COMPLETED · sponsor: **HLT Inc.** · enrollment: 15 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** HLT Transcatheter Aortic Valve System

## Key facts

- **NCT ID:** NCT02838680
- **Lead sponsor:** HLT Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2018-04-09
- **Final completion:** 2022-10-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02838680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02838680, "Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Feasibility Trial CANADA". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02838680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*